Patent ID: 9732386
Date: 2017-08-15
CPC Classifications: A61K,C12Q

Claim:
1. A method of detecting a ratio of telomere length to telomerase activity in a subject, the method comprising the steps of: (a) obtaining from the subject a sample comprising peripheral blood mononuclear cells or leukocytes, wherein the subject is an individual who has been clinically diagnosed with Major Depressive Disorder, (b) detecting a ratio of telomere length to telomerase activity in the sample from the subject that is higher than a ratio of telomere length to telomerase activity detected for a healthy control subject, wherein the detecting comprises measuring telomere length and telomerase activity and wherein the measuring comprises: (c) administering an anti-depressant treatment to the subject, wherein the anti-depressant treatment is anti-depressant medication.